Hybio Pharmaceutical Co., Ltd. (SHE:300199)
China flag China · Delayed Price · Currency is CNY
18.29
-0.01 (-0.05%)
Feb 24, 2026, 1:05 PM CST

Hybio Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
16,16311,38511,99415,52711,1385,917
Market Cap Growth
60.39%-5.08%-22.75%39.41%88.22%14.66%
Enterprise Value
17,97013,12213,71017,02412,7847,126
Last Close Price
18.3012.8913.5817.5812.616.65
PE Ratio
----361.52-
Forward PE
-9.219.219.219.219.21
PS Ratio
18.0019.2927.8022.0515.138.20
PB Ratio
24.2719.0715.3111.976.763.53
P/TBV Ratio
43.0239.9222.3715.448.434.48
P/FCF Ratio
125.41232.96----
P/OCF Ratio
46.5469.12-982.2871.02123.30
PEG Ratio
-0.730.730.730.730.73
EV/Sales Ratio
20.0122.2331.7824.1717.379.87
EV/EBITDA Ratio
70.02115.59----
EV/EBIT Ratio
160.44-----
EV/FCF Ratio
139.42268.51----
Debt / Equity Ratio
2.903.012.591.391.091.16
Debt / EBITDA Ratio
7.5215.72----
Debt / FCF Ratio
14.9736.79----
Net Debt / Equity Ratio
2.692.852.151.190.710.89
Net Debt / EBITDA Ratio
7.0014.99-7.57-29.27-8.09-3.40
Net Debt / FCF Ratio
13.8834.83-19.76-8.85-27.80-7.65
Asset Turnover
0.290.190.130.190.190.17
Inventory Turnover
1.501.441.521.121.580.91
Quick Ratio
0.160.140.360.521.280.74
Current Ratio
0.370.330.480.711.550.95
Return on Equity (ROE)
-10.67%-26.10%-49.56%-25.30%1.71%-31.16%
Return on Assets (ROA)
2.23%-0.64%-6.74%-3.03%-4.26%-7.79%
Return on Invested Capital (ROIC)
4.59%-1.36%-14.00%-6.44%-7.61%-16.48%
Return on Capital Employed (ROCE)
6.80%-2.00%-20.00%-7.40%-8.50%-18.70%
Earnings Yield
-0.42%-1.52%-4.28%-2.39%0.28%-10.30%
FCF Yield
0.80%0.43%-0.71%-1.12%-0.38%-3.31%
Payout Ratio
----375.37%-
Buyback Yield / Dilution
-2.67%2.00%-0.42%14.09%-11.21%-0.19%
Total Shareholder Return
-2.67%2.00%-0.42%14.09%-11.21%-0.19%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.